Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.7M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
20.6M
-
Shares change
-
-44K
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
-$4.28M
-
Put/Call ratio
-
1.44
-
Number of buys
-
111
-
Number of sells
-
-82
-
Price
-
$62.29
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2014
228 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q2 2014.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.6M shares
.
Largest 10 shareholders include BVF INC/IL (1.89M shares), FMR LLC (1.72M shares), RS INVESTMENT MANAGEMENT CO LLC (1.39M shares), BlackRock Fund Advisors (1.3M shares), Knott David M (1.25M shares), VANGUARD GROUP INC (1.04M shares), BLAIR WILLIAM & CO/IL (844K shares), BlackRock Institutional Trust Company, N.A. (593K shares), State Street Corp (572K shares), and CARDINAL CAPITAL MANAGEMENT LLC /CT (568K shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.